You just read:

Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy

News provided by

Jazz Pharmaceuticals plc

02 Dec, 2014, 21:05 GMT